Published in Circulation on January 23, 2006
The right ventricle: interaction with the pulmonary circulation. Crit Care (2016) 1.39
Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study. Crit Care (2013) 0.98
A more aggressive approach to emergency embolectomy for acute pulmonary embolism. Mayo Clin Proc (2010) 0.98
Aggressive approach to pulmonary embolectomy for massive acute pulmonary embolism: a historical and contemporary perspective. Mayo Clin Proc (2010) 0.97
Acute pulmonary embolism. Part 2: treatment. Nat Rev Cardiol (2010) 0.96
Embolectomy for acute pulmonary thromboembolism: from Trendelenburg's procedure to the contemporary surgical approach. Surg Today (2010) 0.94
Management dilemmas in acute pulmonary embolism. Thorax (2013) 0.93
Current treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol (2010) 0.93
Outcome of pulmonary embolectomy for acute pulmonary thromboembolism: analysis of 32 patients from a multicentre registry in Japan. Interact Cardiovasc Thorac Surg (2011) 0.85
Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism. Multidiscip Respir Med (2013) 0.83
Chiari network: a protective filter against pulmonary embolism in a case of polycythaemia. BMJ Case Rep (2012) 0.83
New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities. Drugs (2014) 0.82
Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art. Front Cardiovasc Med (2015) 0.82
Impact of advanced age on the severity of normotensive pulmonary embolism. Heart Vessels (2014) 0.82
Clinics in diagnostic imaging (152). Right lower lobe segmental pulmonary embolus. Singapore Med J (2014) 0.80
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80
Surgical embolectomy for acute massive pulmonary embolism. Int J Clin Exp Med (2014) 0.80
Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Eur Heart J (2011) 0.80
Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary care. Clinics (Sao Paulo) (2016) 0.79
Forearm Compartment Syndrome following Thrombolytic Therapy for Massive Pulmonary Embolism: A Case Report and Review of Literature. Case Rep Orthop (2012) 0.79
Double Bolus Thrombolysis for Suspected Massive Pulmonary Embolism during Cardiac Arrest. Case Rep Emerg Med (2015) 0.79
Experimental model of large pulmonary embolism employing controlled release of subacute caval thrombus in swine. J Vasc Interv Radiol (2011) 0.78
Comparison of clinical and imaging characteristics and outcomes between provoked and unprovoked acute pulmonary embolism in Koreans. J Korean Med Sci (2012) 0.78
Severe hypoxaemia can predict unfavourable clinical outcomes in individuals with pulmonary embolism aged over 40 years. Singapore Med J (2014) 0.78
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. Multidiscip Respir Med (2013) 0.77
Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. J Thromb Thrombolysis (2016) 0.77
Treating venous thromboembolism in patients with cancer. Expert Rev Hematol (2012) 0.77
Safe ECMO femoral decannulation by placement of inferior vena cava filter via internal jugular vein. J Artif Organs (2016) 0.76
Treatment of mobile right heart thrombi with low-molecular-weight heparin. BMJ Case Rep (2013) 0.76
Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients. Clin Exp Emerg Med (2016) 0.75
Percutaneous mechanical thrombectomy for the treatment of acute massive pulmonary embolism: case report. Thromb J (2007) 0.75
Unusual presentation of a massive pulmonary embolism. J Tehran Heart Cent (2011) 0.75
Management of pulmonary embolism with rheolytic thrombectomy. Can Respir J (2011) 0.75
Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study. BMC Pulm Med (2014) 0.75
Thrombolysis treatment for submassive pulmonary thromboembolism in patients with cancer: a safe therapeutic tool. Clinics (Sao Paulo) (2011) 0.75
Mortality Related Risk Factors in High-Risk Pulmonary Embolism in the ICU. Can Respir J (2016) 0.75
The first experience of catheter based pulmonary embolectomy in iran: a new horizon in therapy of massive pulmonary emboli. Iran Red Crescent Med J (2011) 0.75
The Ratio of Descending Aortic Enhancement to Main Pulmonary Artery Enhancement Measured on Pulmonary CT Angiography as a Finding to Predict Poor Outcome in Patients with Massive or Submassive Pulmonary Embolism. Tuberc Respir Dis (Seoul) (2012) 0.75
Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther (2016) 0.75
The masquerade of massive pulmonary embolism. J R Soc Med (2011) 0.75
Tough decisions in pulmonary embolism: thrombolysis or embolectomy? Oxf Med Case Reports (2016) 0.75
Importance of clinical and echocardiographic hemodynamic assessment in chronic pulmonary embolism. J Cardiovasc Ultrasound (2011) 0.75
Right Heart Transvalvular Embolus with High Risk Pulmonary Embolism in a Recently Hospitalized Patient: A Case Report of a Therapeutic Challenge. Case Rep Pulmonol (2015) 0.75
Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism. PLoS One (2015) 0.75
Endovascular thrombectomy with the AngioJet System for the treatment of intermediate-risk acute pulmonary embolism: a case report of two patients. Postepy Kardiol Interwencyjnej (2016) 0.75
Surgical embolectomy in the management of massive and sub-massive pulmonary embolism: The results of 30 consecutive ill patients. ARYA Atheroscler (2015) 0.75
Right ventricular myocardial infarction and pulmonary embolism differential diagnosis--a challenge for the clinician. J Med Life (2010) 0.75
Implications and limitations of the PREPIC2 study-the interventionist's perspective. Cardiovasc Diagn Ther (2016) 0.75
Outcome of thrombolysis for massive pulmonary embolism. Ghana Med J (2009) 0.75
Echocardiography for patients undergoing extracorporeal cardiopulmonary resuscitation: a primer for intensive care physicians. J Intensive Care (2017) 0.75
Surgical Embolectomy for Acute Pulmonary Thromboembolism. Ann Vasc Dis (2017) 0.75
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst (2005) 9.10
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med (2013) 6.71
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol (2007) 5.12
Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis (2011) 4.79
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol (2003) 4.10
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation (2013) 3.73
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol (2009) 3.57
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2004) 3.54
Chronic thromboembolic pulmonary hypertension. N Engl J Med (2011) 3.37
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol (2005) 2.95
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC. J Clin Oncol (2003) 2.65
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med (2003) 2.61
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg (2005) 2.53
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial. J Clin Oncol (2007) 2.48
Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. Radiology (2011) 2.47
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med (2003) 2.47
Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ (2011) 2.34
Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med (2011) 2.32
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol (2005) 2.25
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med (2002) 2.25
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation (2004) 2.21
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11
Upper-extremity deep vein thrombosis. Circulation (2002) 2.09
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation (2004) 1.97
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA (2005) 1.82
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol (2007) 1.80
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med (2005) 1.76
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation (2007) 1.75
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol (2002) 1.75
Patterns of domestic migrations and access to childhood cancer care centres in Italy: a report from the hospital based registry of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Eur J Cancer (2008) 1.73
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care (2004) 1.69
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation (2003) 1.68
Drug utilisation profile in the Italian paediatric population. Eur J Pediatr (2008) 1.67
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med (2005) 1.64
Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Tex Heart Inst J (2013) 1.63
Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest (2007) 1.60
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med (2004) 1.55
Assessing the prognosis of acute pulmonary embolism: tricks of the trade. Chest (2008) 1.54
Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost (2011) 1.52
Medication use evaluation: pharmacist rubric for performance improvement. Pharmacotherapy (2014) 1.52
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med (2011) 1.48
The pathology of gastric cardia: a prospective, endoscopic, and morphologic study. Am J Surg Pathol (2007) 1.48
Use of aliskiren in a 'real-life' model of hypertension management: analysis of national Web-based drug-monitoring system in Italy. J Hypertens (2012) 1.47
Acute pulmonary embolectomy: a contemporary approach. Circulation (2002) 1.44
Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol (2005) 1.42
Diagnosis of acute pulmonary embolism: always be vigilant. Am J Med (2007) 1.41
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest (2002) 1.40
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol (2006) 1.40
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. Am J Med (2009) 1.39
Randomized trial of physician alerts for thromboprophylaxis after discharge. Am J Med (2013) 1.39
Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? Ann Intern Med (2009) 1.36
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol (2005) 1.34
Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation (2003) 1.32
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol (2007) 1.31
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. JACC Cardiovasc Imaging (2011) 1.30
Multislice computed tomography for pulmonary embolism--a technological marvel. N Engl J Med (2005) 1.28
Fibrinolysis for acute pulmonary embolism. Vasc Med (2010) 1.27
Management of massive pulmonary embolism. Circulation (2005) 1.27
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). J Thorac Oncol (2007) 1.25
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography. AJR Am J Roentgenol (2008) 1.22
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost (2010) 1.21
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J (2011) 1.20
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol (2011) 1.19
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost (2005) 1.19
Acute pulmonary embolism: part II: treatment and prophylaxis. Circulation (2006) 1.16
Prospective study of BMI and the risk of pulmonary embolism in women. Obesity (Silver Spring) (2009) 1.14
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material. AJR Am J Roentgenol (2007) 1.14
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med (2007) 1.14
Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest (2005) 1.13
Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg (2007) 1.12
Spiral computed tomography for acute pulmonary embolism. Circulation (2004) 1.12
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12
Warfarin dosing and cytochrome P450 2C9 polymorphisms. Thromb Haemost (2004) 1.12
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol (2009) 1.10
Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol (2003) 1.10
Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis (2007) 1.09
Venous thromboembolism in patients with active cancer. Thromb Haemost (2007) 1.09
Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med (2010) 1.07
Pulmonary embolism: risk assessment and management. Eur Heart J (2012) 1.07